Gossamer Bio, Inc. (GOSS) stock
GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.97−0.27 (-2.40%)
Close on Nov 13, 2026Market cap $67.10MP/E –Yield –
Gossamer Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Gossamer Bio's enterprise value was $14.41M on Nov 11, 2026, against $592.34M a year earlier. Over the last 5 years it ranged from -$168.84M to $877.57M, with a median of -$30.46M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $14.41M | -97.3% |
| 2025 | Dec 31, 2025 | $536.83M | – |
| 2024 | Dec 31, 2024 | -$122.05M | – |
| 2023 | Dec 29, 2023 | -$107.96M | – |
| 2022 | Dec 30, 2022 | -$74.14M | -114.4% |
| 2021 | Dec 31, 2021 | $514.55M | +195.5% |
| 2020 | Dec 31, 2020 | $174.13M | -67.5% |
| 2019 | Dec 31, 2019 | $535.09M | – |
See a number that looks wrong?